Supply chains in the pharmaceuticals industry are experiencing a revolution. Threats such as parallel trading and counterfeit drugs and the requirements of organizations such as the FDA demanding more rigorous controls and traceability; new technologies and new ways of working with wholesalers or alternative distributors, all offer a new flexibility in manufacturing and the ability to respond to immediate opportunities or crises in any given market. Rob Whewell's cutting edge guide explains the nature of these threats and opportunities and provides the means to develop a strategic approach to supply chain that allows you to minimize risk and ensure flexibility and improved long-term profitability.